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Summary To assess the achievement of uniformity of radiobiological effectiveness at different depths in the proton spread-out Bragg peak
(SOBP), Chinese hamster ovary (CHO) cells were exposed to 65-MeV modulated proton beams at the Research Centerfor Nuclear Physics
(RCNP) of Osaka University. We selected four different irradiation positions: 2 mm depth, corresponding to the entrance, and 10, 18 and
23 mm depths, corresponding to different positions in the SOBP. Cell survival curves were generated with the in vitro colonyformation method
and fitted to the linear-quadratic model. With 137CS gamma-rays as the reference irradiation, the relative biological effectiveness (RBE) values
for a surviving fraction (SF) level of 0.1 are 1.05, 1.10, 1.12 and 1.19 for depths of 2, 10, 18 and 23 mm respectively. A significant difference
was found between the survival curves at 10 and 23 mm (P< 0.05), but not between 18 and 10 mm or between 18 and 23 mm. There was a
significant dependence of RBE on depths in modulated proton beams at the 0.1 surviving fraction level (P< 0.05). Moreover, the rise of RBEs
significantly depended on increasing SF level or decreased approximately in correspondence with irradiation dose (P= 0.0001). To maintain
uniformity of radiobiological effectiveness for the target volume, careful attention should be paid to the influence of depth of beam and
irradiation dose.
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The depth-dose curve for the single-energy proton beam has
limited applications in clinical radiation therapy owing to the
excessively narrow high-dose region. This region, also known as
the Bragg peak, can be modulated by appropriate selection of a
distribution ofproton energies to produce a spread-out Bragg peak
(SOBP) or a uniform region of full dose at the depth of interest.
Dose uniformity across a target volume can be achieved with
multiple X-ray beams. However, each X-ray beam features a
greater dose in the entrance region than a corresponding proton
beam, has a dose gradient across the target volume and delivers an
undesirable dose to normal tissues distal to the target. Proton
beams have none of these undesirable characteristics (Suit and
Urie, 1992; Munzenrider and Crowell, 1994; Raju, 1996).
Although SOBP produces an excellent physical dose distribu-
tion, there is a variation of linear energy transfer (LET) values at
different depths in the SOBP, known as the LET gradient, from
proximal to distal SOBP. The proton is a lower LET particle than
other heavy-charged particles; for example, the mean LET values
of the 65-MeV modulated proton beams (SOBP) are always less
than 7 keV .m-' (Courdi et al, 1994).
The achievement of uniformity ofradiobiological effectiveness
for target volumes is always a matter of concern. In fact, there is
no uniformity of LET within target volumes. One study has
suggested that DNA double-strand breaks, potentially lethal
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related to relative biological effectiveness (RBE) (Barendsen,
1994 a, b). At LET values of 6 keV gm-' or less, the relationship
between RBE and LET for protons is not clear and only few data
are available. However, at LET values ranging from about 6 to
30 keV ,um-', RBE values drastically increase, and reach a peak
value at about 30 keV im-' (Belli et al, 1989; 1991; 1993; Folkard
et al, 1989; Prise et al, 1990). We were therefore interested in
whether there is a uniformity of radiobiological effectiveness in a
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Figure 1 The depth-dose distribution for the 65-MeV proton beams at the
RCNR CHO cells were irradiated at depths of 2,10,18 and 23 mm by
modulated proton beams
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Figure 2 Survival curves of CHO cells exposed to 65-MeV modulated proton beams. A, B and C show the first, second and third experiments respectively.
D represents a composition of the three experiments and is called an SMV curve
There are 14 facilities for proton therapy worldwide, and the
number of new facilities continues to increase (Raju, 1996). In
1992, construction was started ofthe biological and medical port in
the azimuthally varying field (AVF) cyclotron of the Research
Center for Nuclear Physics (RCNP), Osaka University, Japan. A
new port was completed at the RCNP in 1993 and is the firstbiolog-
ical and medical port for proton beams developed in western Japan
(Ozeki et al, 1994; Murayama et al, 1995; Tang et al, 1996). Since
1994, we have conducted preclinical experiments as a precursor to
future clinical studies (Tang et al, 1996). This article reports on the
results of radiobiological effectiveness at different depths and
various doses per fraction in 65-MeV modulated proton beams.
MATERIALS AND METHODS
Cell and culture conditions
Chinese hamster ovary (CHO) cells purchased from Dainippon
Pharmaceutical (Osaka, Japan) were used for our experiments,
together with Ham's F-12 medium supplemented with 10% fetal
calf serum and 2 mM L-glutamine (Nikken Biomedical Lab.,
Japan). The cells were grown in a standard culture incubator at
37°C in humidified air containing 5% carbon dioxide. Under these
conditions, the cells have a doubling time of about 13-14 h and a
plating efficiency of about 80-90%. The cells were routinely
cultured in conventional 25-cm2 flasks (Corning, NY, USA) and
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Table 1 Radiation sensitivity parameters exposed to 65-MeV modulated
proton beams and 137CS gamma-rays
cc p S2Gy
(Gy-1) (Gy-2)
137Cs gamma-rays 0.1604 (±0.0218) 0.0246 (±0.0039) 0.657
Entrance (2 mm) 0.1993 (±0.0354) 0.0224 (+0.0067) 0.613
SOBP (10 mm) 0.2074 (±0.0439) 0.0250 (±0.0052) 0.598
SOBP (18 mm) 0.2166 (±0.0357) 0.0256 (±0.0066) 0.585
SOBP (23 mm) 0.2494 (±0.0452) 0.0245 (±0.0077) 0.550
a- and 5-values are mean values and standard deviation. SOBP, spread-out
Bragg peak.
Table 2 Comparison of SMV curves at different depths of proton beams
Survival curves Scheffe Ftest
2-mm curves vs 10-mm curves NS
2-mm curves vs 18-mm curves NS
2-mm curves vs 23-mm curves P < 0.05
10-mm curves vs 18-mm curves NS
10-mm curves vs 23-mm curves P < 0.05
18-mm curves vs 23-mm curves NS
SMV curve is the curve of survival mean values. NS, not significant.
Table 3 RBEs of 65-MeV modulated proton beams comparing with 137CS
gamma-rays at different depth and surviving fractions (SFs) levels
SF level Depth in modulated proton beams (mm)
2 10 18 23
0.80 1.17 (±0.07) 1.22 (±0.06) 1.27 (±0.05) 1.42 (±0.08)
0.67 1.14 (±0.05) 1.19 (±0.06) 1.23 (±0.03) 1.37 (±0.05)
0.37 1.09 (±0.04) 1.14 (±0.02) 1.18 (±0.04) 1.27 (±0.05)
0.10 1.05 (±0.02) 1.10 (±0.06) 1.12 (±0.02) 1.19 (±0.03)
0.05 1.04 (±0.02) 1.09 (±0.04) 1.12 (±0.05) 1.16 (±0.03)
r-values +0.998 +0.999 +0.998 +0.999
RBE values are mean values and standard deviation. r-values are correlation
coefficients of RBEs and SF level.
were repeatedly subcultured through 0.02% EDTA and 0.25%
trypsin (Research Foundation for Microbial Diseases of Osaka
University, Japan). The logarithmic phase cells were used for the
experiments of proton beams and 137CS gamma-rays. Twenty-four
hours before irradiation, the medium ofthe samples was changed,
and after irradiation, the cells were immediately treated with the
EDTA and trypsin. The samples irradiated at different doses were
seeded on five culture dishes (60 mm in diameter, from Coming)
for 1, 2 and 4 Gy and ten culture dishes for 6, 8 and 10 Gy.
Depending on the irradiation dose, appropriate amounts of cells
were seeded onplastic dishes and incubated under standard culture
conditions for 1 week, then fixed with a 99.9% alcohol solution
and stained with a 0.1% Giemsa solution. Colonies containing
more than 50 cells were counted.
Irradiation conditions
Reference irradiation was performed with '37Cs gamma-rays
generated by Gammacell 40 Exactor (Nordion International,
Canada). The dose rate was 1.27 Gy min-', and doses ranged from
Oto 10Gy.
The 65-MeV proton beams were generated from the AVF
cyclotron of the RCNP. Our proton irradiation system consisted
mainly ofa beam control unit, a beam-forming unit, a beam moni-
toring unit and a sample change unit, which included two wobbler
magnets, a beam scatterer, a beam viewer, a range shifter, a range
modulator, a beam monitor and a sample changer. The range
shifter is used for degrading the proton energy and the range
modulator for construction of SOBP. Details of the facility have
been reported in previous publications (Ozeki et al, 1994;
Murayama et al, 1995; Tang et al, 1996).
The flasks ofcell cultures were irradiated in the sample changer
unit with a dose rate of approximately 2-4 Gy min-'. The
maximum range of depth-dose distribution corresponded to a
beam energy of approximately 65 MeV owing to energy loss in
beam-shaping devices and in the air. In fact, the energy levels of
the proton beams varied from 64.5 MeV to 64.8 MeV during the
three experiments. Figure 1 shows the depth-dose profiles and the
various positions of irradiation. Survival data of clonogenic cells
were obtained for CHO cells irradiated at the 2 mm depth corre-
sponding to the entrance and at 10, 18 and 23-mm depths corre-
sponding to the three different positions in the SOBP.
The dose determination procedure using the ionization chamber
follows the recommendations given in the American Association
of Physicists in Medicine (AAPM) protocol for heavy-charged
particle dosimetry (AAPM, 1986). The ionization chamber
reached from the plateau to the unmodulated Bragg peak region of
a monoenergetic beam and the absorbed dose was monitored.
When a rotating range modulator was set up at the port, the
absorbed dose at the SOBP was also measured.
Data analysis
For analysis, the cell survival data were fitted to the linear-
quadratic model, whose parameters a and A were calculated by
computer. The survival level at a dose of2 Gy (S2Gy) is claimed to
be the conventional parameter of clinical radiation response and
was also calculated from the curves of the linear-quadratic model.
RBE values were obtained from the survival mean values (SMV)
curves of three experiments at survival levels 0.8, 0.67, 0.37, 0.1
and 0.05, whichroughly corresponds to 1 Gy, 2 Gy, 4 Gy, 6 Gy and
8 Gy respectively. For the analysis of survival curves, the homo-
geneity ofvariances was tested with the F-test. When the variance
was homogeneous, one-way analysis ofvariance (Scheffe F-test of
multiple comparison) was applied (Mould, 1994). The relationship
between RBE and surviving fraction (SF) level and depth in the
proton beams was tested by the regression method. A P-value of
less than 0.05 was considered to be significant.
RESULTS
We carried out three experiments to investigate the radiobiological
effectiveness at different depths in 65-MeV modulated proton
beams. Survival curves for the first, second and third experiments
at the four different depths and with '37Cs gamma-rays are shown
in Figures 2A-C respectively. Figure 2D represents a composition
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l- 0.8, 0.67, 0.37, 0.1 and 0.05 (Table 3). The RBEs were then calcu-
lated from SMV curves (Figure 2D) using the linear-quadratic
model. At any levels of the surviving fractions, RBE values
increase proportionally to the increase of modulated proton
beams' depth. At an SF level of 0.1, RBE values were 1.05
(± 0.02), 1.10 (± 0.06), 1.12 (± 0.02) and 1.19 (± 0.03) for depths
of 2, 10, 18 and 23 mm respectively. The regression statistical
method was used to establish the relationship between RBE and
SF level (Table 3). The correlation coefficients are +0.998, +0.999,
+0.998 and +0.999 for the depths of 2, 10, 18 and 23 mm respec-
tively, and show a close relationship with RBEs and SF level. A
highly significant correlation was found between RBEs of all
depth and different SF levels (P = 0.0001) (Figure 3) The increase
of RBEs significantly depends on increasing SF level, with
i _l_ decreasing levels roughly corresponding to irradiation dose.
0.8 1 The regression statistical method was also used to establish the
relationship between RBE and depth in modulated proton beams
arent SF levels at (Figure 4). The correlation coefficients (r) and P-values are
+0.916, P = 0.07; +0.928, P < 0.05; +0.955, P < 0.05 and +0.981,
P < 0.05 for the 0.8, 0.67, 0.37, 0.10 and 0.05 SFs level respec-
tively. All correlation coefficient values show a close relation with
RBE and depths ofSOBP. Furthermore, we can clearly understand
the mutual relationships of RBEs with depths of beam and SF
level from Figure 4. RBEs are significantly correlated with depth
of modulated beams and increase gradually with increasing
SFs level.
DISCUSSION
There have been few studies concerning the uniformity of radio-
biological effectiveness in proton SOBP with LET less than
_~ < v 6 keV gm-'. The reason for this may be that radiobiological effec-
tiveness is thought to be represented by uniformity, because
typical graphs ofother heavy-particle beams showing the relation-
ship between LET and RBE suggest that when LET values are less
, ,,,i ,_than 10 keV im-' the changes in RBE are not obvious (Belli et al,
10 15 20 25 1989; Barendsen etal, 1993; 1994b; Hall, 1994). A report from the
Harvard Cyclotron Group showed that an increase in RBE values
nodulated proton beams (mm) was related to depth in 160-MeV proton beams SOBP (Robertson
n RBE and depth in 65-MeV modulated et al, 1975). However, the results ofother in vivo or in vitro exper-
sof 0.8, 0.67, 0.37, 0.10 and 0.05 using the iments by the same group suggested that RBE in the incident
plateau was not significantly different from that in SOBP (Hall et
al, 1978; Urano et al, 1980).
Several special studies on this subject have been completed in
alled an SMV curve. The radiation Europe during the last few years. In France, human melanoma
MV curves are presented in Table 1. cells were exposed to 65-MeV proton beams, with the results indi-
aes is seen following an increase in cating the RBE depended on depths in SOBP or changes of LET
ton beams, ranging from 0.1993 to (Courdi et al, 1994). Very recently, the radiation response of the
is seen in 1-values. Furthermore, S2Gy CHO cell line to 85-MeV proton beams was tested at four different
ase following an increase in depth in SOBP positions, but no significant differences in RBEs at various
depths in proton beams were identified (Gueulette et al, 1996).
d was used to establish the SMV These experiments all adopted the typical, universal and accurate
fferent depths in proton beams (Table colony formation method, so that the results cannot be dismissed.
ference was found among the four Our data have demonstrated that radiobiological effectiveness
rent irradiation depths (P = 0.0001). strongly depends on depth in 65-MeV proton beams, and therefore
s indicated that the survival curve at agree with the results of the French study. Thus, the universal
er than those at 2 and 10 mm, but not CHO cell line was used in our experiments but not a sensitive or
{as no significant difference between non-sensitive cell line. Because the character ofdifferent depths in
mm. proton beams is actually related to changes in LET (Courdi et al,
Is at four different depths compared 1994, Gueulette et al, 1996), the radiobiological effectiveness can
a-ray was calculated at SF levels of be considered to depend on LET.
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Our data also show that there is no significant difference
between survival curves at depths of 18 and 10 mm or of 18 and
23 mm. However, a significant difference was observed between
survival curves of 10 and 23 mm. These results suggest that radio-
biological effectiveness depends on depths in proton beams. Ifthe
proton beams are used to irradiate tumours, importance must
be attached to uniformity of radiobiological effectiveness within
target volumes. Because the SOBP used in clinical therapy is
larger than the experimental SOBP, research into, and discussion
of, the uniformity of radiobiological effectiveness at different
depths in SOBP used for clinical therapy should be continued. In
the meantime, when planning radiotherapy, we should exhaust
every possible means to maintain uniform distribution of radio-
biological effectiveness within target volumes.
We compared changes in RBE values at the SF level of 0.8,
0.67, 0.37, 0.10 and 0.05, which roughly corresponds to I-Gy,
2-Gy, 4-Gy, 6-Gy and 8-Gy fractions. A clear result was obtained
showing that the increase in RBE values depends on increasing SF
level or decreasing irradiation dose. Although similar results
concerning the dependence of RBE on irradiation dose have been
obtained by other authors, we still have no clear explanation for
this phenomenon (Hall et al, 1978; Cucinotta et al, 1991;
Blomquist et al, 1993). Blomquist et al (1993) obtained a high
RBE value of 1.63 at the 0.5 SF level compared with 1.28 and 1.15
at the 0.1 and 0.01 SF level in V79-379A cells. Urano et al (1980)
considered the significance of these differences to be unclear, and
it may be the cause ofexperimental error or other error. One study
analysed the phenomenon using the cellular track model. It was
found that, at high dose, proton-produced damage was similar to
that produced by gamma-rays. On the other hand, at low dose, the
radiobiological effectiveness of proton was very different from
that of gamma-rays (Cucinotta et al, 1991). There have also been
other studies that did not definitely support the difference (Yashkin
et al, 1995; Gueulette et al, 1996). We found a definite correlation
between RBE and SF level or irradiation dose. As the relationship
between RBE and irradiation dose is very important in the radio-
therapy field, further research is needed.
Accurate determination ofRBE is required in radiation therapy
as a dose variation of 5% can be detected in some clinical situa-
tions (Menzel et al, 1987). This is especially true for proton beam
therapy because high doses are often prescribed for target
volumes close to, or adjacent to, critical radiosensitive normal
structures. As the dose prescribed for a patient is directly related
to the selected clinical RBE, an accuracy of 5% is also required
for the determination ofthe RBE (Gueulette et al, 1996). Our data
showed that RBEs, at the 0.1 SF level, corresponding to the 6-Gy
fraction region, are 1.10, 1.12 and 1.19 at depths of 10, 18 and
23 mm respectively. The differences in RBEs were less than 5%
between 18 and 10 mm, but were greater than 5% between 10 and
23 mm and between 18 and 23 mm. Moreover, at the 0.67 SF
level, corresponding to the 2-Gy fraction region, RBE values of
1.19, 1.23 and 1.37 were obtained at depths of 10, 18 and 23 mm
respectively. The differences in RBE values at the 0.67 SF level
were more than 10%. Thus, differences of more than 10% may
result in serious problems of non-uniform radiobiological effec-
tiveness in target volumes. The non-uniform distribution ofradio-
biological effectiveness may in fact be directly related to the
non-control and recurrence of some tumours, and has great
significance for clinical radiotherapy. Therefore, we should pay
careful attention to obtaining an accuracy of 5% in RBE in
clinical radiotherapy.
Although this study involved in vitro experiments, the results
should help current clinical therapy, as the results of studies of
radiobiological effectiveness are universal. On the other hand, the
absolute value of RBE may, to some extent, depend on the tissue,
cell line or experimental end point (Urano et al, 1980). Actual and
individual data are the most important for any facility. To identify
common characteristics, othercell lines and tissues should be eval-
uated for uniformity of radiobiological effectiveness at different
facilities.
CONCLUSIONS
This study of radiation responses at the RCNP AVF cyclotron's
biological and medical port with CHO cells exposed to 65-MeV
modulated proton beams compared with 137Cs gamma-rays led to
the following conclusions:
1. Although modulated proton beams have an excellent physical
dose distribution, RBE values depend on the depths in the
proton beams.
2. Regarding the relationship between RBE and SF level, an
increase in RBE significantly depends on increasing SF level
or decreasing iffadiation dose.
3. Because different irradiation depth and dose may influence the
distribution ofradiobiological effectiveness within target
volumes, further research is necessary.
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